Nemat Khansari, PhD, CP
Dr. Nemat Khansari, a retired Professor of Immunology at Tehran Medical School, currently serves as Editor-in-Chief of the International Journal of Vaccine & Vaccination. He earned his DVM from the University of Tehran and completed his PhD in Immunology at the University of Illinois at Urbana-Champaign. With decades of experience in biomedical research, Dr. Khansari has specialized in immunotherapy, cell culture technology, and stem cell research, establishing himself as a leader in advancing innovative therapies and clinical immunology practices.
Throughout his career, Dr. Khansari has held multiple leadership positions, including Director of a Medical Diagnostic Laboratory in Tehran, Chairman of the Board, and Member of the Board of Directors at Gandhi Hotel Hospital. He has also served as a compliance officer for biosafety and directed highly specialized teams performing clinical immunology testing, cell sorting, and preparation for immunotherapy strategies. His work and leadership have been recognized by his election to Marquis Who’s Who in 2022.
Beyond his professional roles, Dr. Khansari is passionate about teaching immunology, mentoring emerging scientists, and advancing knowledge in aging and immunotherapy. He is dedicated to bridging scientific discovery with practical clinical applications, inspiring the next generation of researchers, and promoting innovation in biomedical science.
• University of Illinois Urbana-Champaign - PhD
• University of Tehran - DVM
• Certificate of Clinical Competence in Speech-Language Pathology
• Co-founder -
Iranian AIDS Prevention Society
Dr. Nemat Khansari has published extensively in the field of cancer immunology, including over a dozen books and peer-reviewed articles. Notable works include Most Frequent Bacteria in Colorectal Cancer Patients and Their Roles in Colorectal Carcinogenesis (CPQ Microbiology, 2020), Improving Clinical Efficacy of Cancer Vaccines Using Neoantigen Identified in Cancer Patients (Vaccines & Vaccination Open Access, 2019), Neoantigen: A New Hope for Effective Cancer Immunotherapy (Vaccination Research, 2019), Opinion: Patient Tumor Specific Antigen Can Be Used as an Individualized Cancer Vaccine for Effective Treatment of Patient, Salmonella-Based Anticancer Vaccine and Their Efficacy (Vaccination Research, 2019), Is Immunotherapy a Suitable Treatment Modality for Cancer? (Int. J. Vaccine and Vaccination, 2018), New Hope for Cancer Immunotherapy; Viral Based Cancer Vaccines (Significance of Bioeng. BioSci., 2018), Role of Bacterial Infection in the Development and Progression of Gastric Cancers (MOJ Immunology, 2018), Role of Environmental Factors in Evolution of Cancer (CPQ Microbiology, 2018), Anticancer Dendritic Cell Vaccines Producing Effective Anti-Tumor T Cell Responses (J. Vaccine and Vaccination, 2017), Immunobiology of Anticancer Virotherapy with Newcastle Disease Virus in Cancer Patient (Vaccine Res. Open J., 2017), and Virotherapy with Newcastle Disease Virus for Cancer Treatment and Its Efficacy in Clinical Trials (MOJ Immunology, 2017).
What do you enjoy most about practicing medicine?
What I enjoy most about practicing medicine is the opportunity to combine teaching, research, and leadership in the field of immunology. I am passionate about educating the next generation of scientists and clinicians, advancing research in aging and immunological health, and applying scientific discoveries to improve patient care. During my tenure at the Iranian Pasteur Institute, I established the Biotechnology Division and served as Professor and Vice President of the Department of Immunology, experiences that allowed me to shape both scientific programs and institutional growth while mentoring future leaders in the field.